3137 results for «2375»
3137 results
Aortic valve disease: treatment and patient selection
21 Nov 2021 – From PCR London Valves 2021
Let's talk about severe asymptomatic aortic stenosis: what are the surgical standpoint and recent data from surgical literature? How to assess these patients? How to analyze CT? What do the newly published VHD Guidelines say? What is the place of MRI in these patients? So many questions...
TAVI in bicuspid aortic valves: optimal technique and procedural refinement
21 Nov 2021 – From PCR London Valves 2021
Framed around a "live-in-a-box" case performed in Toulouse, the core of this session will be on procedural technique: how do you best perform a TAVI to get optimal outcomes in bicuspid anatomy? It will also focus on preprocedural planning, and in particular CT image analysis, and detail...
Aortic stenosis in the younger patient: procedural complications and lifetime management
21 Nov 2021 – From PCR London Valves 2021
Biological, surgical valves and TAVIs are being implanted in younger and younger patients. Since these procedures must be planned in the best possible way to minimize future complications, and because the lifetime management of these patients must be thought of, watch this session to get very useful...
Tricuspid transcatheter edge-to-edge repair
21 Nov 2021 – From PCR London Valves 2021
This session from PCR London Valves 2021 will focus on the most commonly performed tricuspid procedure: transcatheter edge-to-edge. Review the two technologies currently available, learn tips and tricks, share your experience, and examine all aspects, including imaging.
Tricuspid valve disease: diagnosis and treatment selection
22 Nov 2021 – From PCR London Valves 2021
Presented during PCR London Valves 2021, view the case of an 85-year-old patient with hypertension, diabetes, and dyslipidemia, who has permanent atrial fibrillation and renal failure, but no left-sided valvular heart disease and follow the debates around which treatments to adopt!
Aortic valve disease: state-of-the-art
22 Nov 2021 – From PCR London Valves 2021
This PCR London Valves 2021 session begins with important updates on the seminal trials that have defined our TAVI era over the past decade before moving on to new studies that are very likely to shape the evolution of TAVI in the next ten years.
Transcatheter tricuspid valve interventions: optimal technique and procedural refinement
22 Nov 2021 – From PCR London Valves 2021
With this session from PCR London Valves 2021, learn more about a procedure that is becoming increasingly popular and reproducible: the transcatheter tricuspid valve intervention. Pre-procedural planning, successful management of major complications, and requirements for implementing a program at your center are key topics.
Aortic valve disease: guidelines and beyond
22 Nov 2021 – From PCR London Valves 2021
Through this PCR London Valves 2021 session, compare the new ESC aortic valve disease guidelines with the US guidelines, focus on controversies and uncertainties of these AVD guidelines, see how to apply the guidelines using the Heart Team decision-making concept, and appreciate in a live case...
Transcatheter tricuspid valve interventions: prevention of complications and their management
22 Nov 2021 – From PCR London Valves 2021
Watch this session from PCR London Valves 2021 if you want to find out more about the complications you may encounter during transcatheter tricuspid valve procedures, learn more about how to schedule and prepare for these interventions to avoid complications, and get more tips and tricks...
TAVI: the future
22 Nov 2021 – From PCR London Valves 2021
This session from PCR London Valves 2021 particularly focuses on the expected expansions of TAVI to patients at a younger age and with a longer life expectancy, including a virtual live case from Clinique Pasteur, Toulouse, France.
Mitral valve disease: diagnosis and treatment selection
23 Nov 2021 – From PCR London Valves 2021
In the first part of this PCR London Valves 2021 session, review the quantification of mitral regurgitation and learn how to better approach patients. Then, in the second part, study patient selection for specific types of procedures.
Tricuspid valve disease: state-of-the-art
23 Nov 2021 – From PCR London Valves 2021
Imagine that you are faced with a patient with severe tricuspid regurgitation. You may ask yourself many questions, such as: what could be the prognosis of this patient? What is his/her life expectancy? Is he/she eligible for a particular treatment? What should be the appropriate timing...
Transcatheter mitral valve repair and replacement: optimal technique and procedural refinement
23 Nov 2021 – From PCR London Valves 2021
This PCR London Valves 2021 interactive learning session is designed to review the basics but also the more advanced and complex procedural steps of transcatheter mitral edge-to-edge repair, as this procedure requires a rigorous and standardized technique that can take time to learn.
Tricuspid valve disease: guidelines and beyond
23 Nov 2021 – From PCR London Valves 2021
Watch this PCR London Valves 2021 session to hear about the latest European guidelines on the management of tricuspid valve disease, understand the details behind these guidelines and how they compare with those elsewhere in the world, and, most importantly, find out how Heart Teams can translate...
Transcatheter mitral edge-to-edge repair: procedural complications and lifetime management
23 Nov 2021 – From PCR London Valves 2021
This PCR London Valves 2021 session presents different kinds of complications in mitral procedures based on clinical cases: discuss the case of an 82-year-old male patient with symptomatic severe ischemic secondary mitral regurgitation, coronary artery disease, diabetes, and chronic kidney disease, among others!
Transcatheter tricuspid valve interventions: the future
23 Nov 2021 – From PCR London Valves 2021
In this PCR London Valves 2021 session, observe the case of an 84-year-old, not overweight, quite active, female patient with a past history of restrictive cardiomyopathy and permanent atrial fibrillation, who presented with worsening dyspnea and obvious clinical signs of right ventricular heart failure, and discuss the...
Closing Ceremony
23 Nov 2021 – From PCR London Valves 2021
Looking back on some of the key moments of the PCR London Valves 2021, it is clear that we witnessed cutting-edge procedures in all three valves, pushed the guidelines to the limits and beyond, saw the future of valve procedures with a new TAVI device implanted, live-implanted...
What's new in antiplatelet therapy post-PCI in 2021?
16 Dec 2021 – From GulfPCR-GIM 2021
From concrete clinical cases, discover the discussions led by our experts who wonder about the post-PCI antiplatelet treatment, and learn how to integrate evidence in daily clinical practice and to individualize DAPT strategies after PCI in 2021.
Year in review: the most impactful trials and papers in interventional cardiology in 2021
16 Dec 2021 – From GulfPCR-GIM 2021
While reflecting on the real academic milestones in the last couple of years, get key learnings for clinical practice from five selected trials published in 2021, and examples of how to critically appraise the internal and external validity of randomised clinical trials, among others.
Challenging STEMI and MVD scenarios
16 Dec 2021 – From GulfPCR-GIM 2021
In this session, five challenging STEMI cases are discussed so as to enable you to find out how to manage complex primary PCI in STEMI with multivessel disease (MVD).
